Company intelligence / Profile preview

Probatech

London, England, United Kingdomprobatech.co.uk ↗

Ownership: Private
Employees: ~2
Development stage: Other

Overview

Probatech is an international business development consultancy specializing in bridging the early-stage innovation gap in life sciences. It connects pharma companies and investors with start-ups developing new drugs, vaccines, or platform technologies. The company has supported over 20 companies and facilitated more than $1 billion in licensing, financing, and acquisitions for clients across Europe, the US, and Asia[1][2].

Modalities: Small moleculeMonoclonal antibodyVaccine
Industry: Consulting

Beyond the preview

Go deeper on Probatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probatech.

Explore the full profile